#herpes marker testing market
Text
0 notes
Text
Global Herpes Marker Testing Market By Type (HSV-1,HSV-2,HSV-1/ HSV-2), By Application (ResearchClinic), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Industry analysis and future outlook on Herpes Marker Testing Global Market brings a systematic perspective of the market execution and assists in strategic decision making for worldwide and additionally the regional situation. Detailed sections provides in-depth arrangement, the Herpes Marker Testing contemplate that make sense of different perspectives relating to the global market. To begin with, the Herpes Marker Testing market definition, applications, arrangement, and industry esteem chain structure are incorporated into the answer, to target gathering of people on restricting Herpes Marker Testing market elements including drivers, limitations, openings, patterns, applications, topographical/local Herpes Marker Testing markets, and aggressive scene.
Global Herpes Marker Testing Industry Market was valued at USD XX Million in the year 2020. The market is further estimated to grow at a CAGR of XX% from 2020 to reach USD XX Million by the year 2029.
Get Quick Free Sample Brochure report at: https://www.globalresearchview.com/report/global-herpes-marker-testing-market-by-t/GRV52869/request-sample/
Herpes Marker Testing market rivalry by top makers/players, with Herpes Marker Testing deals volume, Value (USD/Unit), Revenue (Mn/Bn USD) and market size for every producer/player; the significant players include:
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics
Worldwide Herpes Marker Testing statistical surveying report uncovers that the Herpes Marker Testing business will develop with pivotal CAGR over the estimated forecast period of 2021 and 2029. The global Herpes Marker Testing market in forecast years 2021-2029, is expected to hit Mn/Bn$ XX USD by 2029. The Herpes Marker Testing market gives broad development openings over the both created and creating economies. Further, the Herpes Marker Testing business sectors could profit without a doubt from the expanding interest to bring down Herpes Marker Testing expenses of treatment over the globe.
Inquiry for Buying report to get customization at: https://www.globalresearchview.com/report/global-herpes-marker-testing-market-by-t/GRV52869/inquiry
Key Highlights of the Report:
Herpes Marker Testing Market Report provides forecast and industry outlook for the period of 2021-2029 with 2020 as the base year and covering historic data for years 2015-2019.
Herpes Marker Testing Market outlook with Porter’s 5 Forces Analysis will provide market dynamics (Drivers, Restraints, Opportunities & Threats).
Herpes Marker Testing Competitive landscape section gives you the competitive edge over other key players in the market (Key Business Strategies, Recent Development M&A, Company Overview, Products/Services Portfolio & Financial Overview).
Herpes Marker Testing Technological Scenarios & Expected Developments.
Herpes Marker Testing End-Use Industry & Consumer Behaviour Trends.
Herpes Marker Testing Export-Import Scenario.
Herpes Marker Testing Regulatory Policies across each region.
Herpes Marker Testing In-depth analysis on Industry Trends & Dynamics across each segment covered in the report.
Based on Type, Herpes Marker Testing market report shows development rate of each type, covers:
HSV-1
HSV-2
HSV-1/ HSV-2
End clients/applications, Herpes Marker Testing market report centers around the status and viewpoint for best applications/end clients, development rate for every application, this can be isolated into:
Research
Clinic
Access More Information at: https://www.globalresearchview.com/report/global-herpes-marker-testing-market-by-t/GRV52869
In conclusion, the global Herpes Marker Testing industry report unveils research finding, outcomes, conclusions. Likewise, disclose various Herpes Marker Testing data sources, traders/vendors, suppliers, manufacturers, sales channel, and addendum. In short, the overall Herpes Marker Testing report is a lucrative document for people implicated in Herpes Marker Testing market.
Global Impact of COVID-19 Analysis:
COVID19 is an unrivaled global public health emergency that affects almost every industry, so the projected long-term impact will affect industry growth over the forecast period. The report provides insights into COVID19, taking into account changes in consumer behavior and demand, purchasing behavior, supply chain diversion, the dynamics of current market forces, and significant government intervention. Insights, analysis, estimates and forecasts considering the impact of COVID19 on the market.
About Us:
GlobalResearchView (GRV) is one of the leading market research company which aims to serve the most excellent research to the various sectors of business. We are prominent in satisfying all kinds of market research needs.
Contact US:
Jennifer Da (Head Global Business Development) – Global Research View(GRV)
701, Milton Avenue,
East Ham,London. United kingdom.
Pincode - 4E6 1BN
Email: [email protected]
Websites: www.globalresearchview.com
Tel: +44 020 8638 7098
0 notes
Text
Global Herpes Marker Testing Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028
This report studies the Herpes Marker Testing market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Herpes Marker Testing in these regions, from 2017 to 2028, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Request a Sample of this report @ https://bit.ly/3KR5Xej
Market Snapshot, By Product Type
HSV-1
HSV-2
HSV-1/ HSV-2
Market Snapshot, By Application
Research
Clinic
Main Market Players Analyzed in this report, including:
Thermo Fisher Scientific, Inc.
Teco Diagnostics
Quidel Corporation
Qiagen N.V.
Norgen Biotek Corp.
Meridian Bioscience Inc
Merck KGaA
Luminex Corporation
Hologic Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
BioMérieux SA
Bio Rad Laboratories Inc.
Abcam Plc
Abbott Laboratories
The study objectives of this report are:
To study and analyze the global Herpes Marker Testing market size (Million USD) by company, key regions/countries, products and application, history data from 2017 to 2021, and forecast to 2028.
To understand industry structure of Herpes Marker Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Herpes Marker Testing manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Herpes Marker Testing market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Herpes Marker Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Herpes Marker Testing are as follows:
History Year: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Year 2023 to 2028
This report includes the estimation of market size from top-down approach by analysing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2021 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
BROWSE FULL REPORT@ https://bit.ly/3uc5E7V
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
2 Market Development Performance under COVID-19
3 3 Industrial Lift Cycle and Main Buyers Analysis
4 Market Segment: by Type
5 Market Segment: by Application
6 Marke Segment: by Region
7 North America
8 Europe
9 Asia Pacific
10 South America
11 Middle East and Africa
12 Key Participants Company Information
Company Information
12.1.2 Thermo Fisher Scientific, Inc.
Key Development
12.2 Teco Diagnostics
Company Information
12.2.2 Teco Diagnostics
Key Development
12.3 Quidel Corporation
Company Information
12.3.2 Quidel Corporation
Key Development
12.4 Qiagen N.V.
Company Information
12.4.2 Qiagen N.V.
Key Development
12.5 Norgen Biotek Corp.
Company Information
12.5.2 Norgen Biotek Corp.
Key Development
12.6 Meridian Bioscience Inc
Company Information
12.6.2 Meridian Bioscience Inc
Key Development
12.7 Merck KGaA
Company Information
12.7.2 Merck KGaA
Key Development
12.9 Hologic Inc.
Company Information
12.9.2 Hologic Inc.
Key Development
12.8 Luminex Corporation
12.8.1 Luminex Corporation
Company Information
12.8.2 Luminex Corporation
Key Development
12.11 DiaSorin S.p.A.
Company Information
12.11.2 DiaSorin S.p.A.
Key Development
12.12 BioMérieux SA
Company Information
12.12.2 BioMérieux SA
Key Development
12.13 Bio Rad Laboratories Inc.
Company Information
12.13.2 Bio Rad Laboratories Inc.
Key Development
12.14 Abcam Plc
Company Information
12.14.2 Abcam Plc
Key Development
12.15 Abbott Laboratories
Company Information
12.15.2 Abbott Laboratories
Key Development
13 Global Herpes Marker Testing Market Forecast by Region by Type and by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
To Make an Enquiry before buying this Global Market Report @ https://bit.ly/3u7mEfr
Contact Us:
Email Address: [email protected]
Phone Number: +1-857-300-1122
Office Address: 5708, Copper Creek Court, Charlotte, North Carolina 28227, USA
0 notes
Text
Herpes Marker Testing Market to Develop Rapidly by 2023
Herpes Marker Testing Market: Overview
Owing to the high prevalence of herpes simplex virus of both types, HSV- 1 and HSV- 2, the demand for herpes marker testing is receiving a stimulus. According to estimates of Centers for Disease Control and Prevention, each year in the U.S., 776,000 people get new genital herpes infections. Countrywide, 11.9% of the population aged between 14 and 49 years have HSV-2 infection, with African- American female population mainly affected.
Furthermore, according to data presented by the Public Health Agency of Canada, prevalence of HSV-1 infection is higher than HSV-2 in most parts of the world. The data also shows seroprevalence in adults is above 70% in developed countries, and almost 100% in developing and underdeveloped countries.
The study on the herpes marker testing market provides a pinpoint analysis of demand dynamics, growth indices, and vendor landscape of the said market for the 2015 – 2023 forecast period.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5510
Herpes Marker Testing Market: Key Trends
Growth of herpes marker testing market stems from ubiquity of herpes virus and asymptomatic nature of the infection. More than 80% herpes infections are asymptomatic, because of which physicians depend on diagnostic tests for correct diagnosis and treatment. Some symptoms of herpes infection are blistering sores, swollen lymph nodes, pain during urination, and fever.
Request for Analysis of COVID19 Impact on Herpes Marker Testing Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=5510
High risk of contraction of herpes virus by close contact with an infected individual is pushing the growth of herpes marker testing market. The virus is transmitted through body fluids such as blood, saliva, and semen. Some studies suggest herpes virus is transmitted through breast milk.
Less number of diagnostic tests available for herpes simplex virus (HSV) is another factor behind growth of herpes marker testing market. Currently, there are four tests available for HSV biomarker testing, namely, antigen tests, cell culture tests, polymerase chain reaction, and antibody tests. Of all, polymerase chain reaction tests are most accurate for diagnosis of HSV. Whilst, cell culture tests have chance of false negative results, and are time consuming too. This arouses need for new diagnostic tests for HSV biomarker testing.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=5510
Herpes Marker Testing Market: Geographical Analysis
North America, among all, is the forefront in terms of clinical trials for herpes marker testing. Medical insurance coverage for HSV testing and presence of state-of-the-art testing facilities are other factors that make the region prominent. High awareness among individuals to seek medical testing for symptomatic HSV also accounts for substantial revenue of the region in the overall herpes marker testing market. Furthermore, higher seroprevalence of HSV and large number of HIV patients are some other factors that pushes growth of North America herpes marker testing market.
On the other hand, limited knowledge of HSV among individuals of developing countries is a factor for small revenue of Asia Pacific herpes marker testing market. Due to the economic conditions and limited medical facilities, cost-effective diagnosis tests are in high demand in developing countries of Asia Pacific.
Pre-book Herpes Marker Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=5510<ype=S
Herpes Marker Testing Market: Competitive Landscape
Keen players in the herpes marker testing market are making strides for diagnostic tests for HSV1- and HSV- 2. R&D and clinical trials is the focus of top players in the herpes market testing market. In 2014, Simplexa HSV 1 and HSV 2 direct molecular test by Quest Diagnostics are the first ones to receive U.S. FDA’s approval. The Simplexa test is the first one approved by U.S. FDA that enables qualitative differentiation and detection of HSV-1 and HSV- 2 in cerebrospinal fluid.
Some other top players in the herpes marker testing market are Trinity Biotech, Biohelix, Focus Diagnostics, DiaSorin, Roche, Thermo Fisher Scientific, and Enzo Life Sciences.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/presence-of-large-insulin-dependent-diabetic-population-expand-avenue-in-self-injection-device-market-pen-injectors-to-account-for-sizable-revenue-share-says-tmr-301260639.html
https://www.prnewswire.com/news-releases/overwhelming-cases-of-drug-driving-accidents-underscores-growth-in-roadside-drug-testing-devices-market-authorities-consider-use-of-technology-to-support-testing-tmr-301266637.html
https://www.prnewswire.com/news-releases/technological-advancements-like-3d-printing-and-an-increase-in-the-number-of-amputations-due-to-various-factors-will-serve-as-growth-pillars-for-the-prosthetics-market-says-tmr-301271549.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
0 notes
Link
0 notes
Link
0 notes
Text
Herpes Markers Testing Market to Witness Rapid Increase in Consumption During 2017 – 2025
According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’, the global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025). The overall market is anticipated to grow 1.7x in terms of value over the forecast period.
Market Dynamics
Certain factors such as positive diagnostic lab industry dynamics, increasing herpes prevalence, rising awareness, support from various government and non-government organizations, new product approvals and launches, increasing focus on evidence based medicines etc. are boosting revenue growth of the market. However, insufficient R&D initiatives, poor access to diagnostic services in remote areas, pricing pressures, and stringent regulations are some of the factors restricting growth of the market.
Segmental Forecast
On the basis of test type, the market has been segmented into viral culture test, nucleic acid amplification-based kits and antibody/antigen-based kits. Antibody/Antigen based kits is the highest revenue generating segment over the forecast period owing to the huge product availability as well as high physician preference for this test type. Nucleic Acid Amplification-based kits segment will report the highest growth rate over the forecast period due to the growing acceptance of PCR diagnosis as a gold standard test in herpes testing owing to high sensitivity, specificity and positivity ratio for herpes diagnosis. Antibody/Antigen based kits is projected to be the most attractive segment with an attractiveness index of 1.5 during the forecast period.
Based on the indication, the market has been segmented into HSV-1, HSV-2 and HSV-1/ HSV-2. HSV-1/HSV-2 segment dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. HSV-1/HSV-2 is projected to be the most attractive segment with an attractiveness index of 1.6 and growth rate of 6.5% during the forecast period.
Request to Sample Report @ https://www.persistencemarketresearch.com/samples/4185
On the basis of application, the market has been segmented into research use and clinical diagnostics segment. Clinical diagnostics application dominates the market for herpes marker testing with a value share in excess of 85% throughout the forecast period.
Based on end user, the market has been segmented into hospitals, diagnostics centers, clinics and academic & research institutes. Among all the end users, most of the revenue is generated via the diagnostic centers sales followed by hospitals owing to the maximum number of tests being performed at these facilities. Diagnostics centers dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. This segment represents a market attractiveness index of 1.6 over the forecast period.
Among the regional markets, North America holds the maximum value share in the global market owing to the accessibility and affordability of diagnostic services in the region and a favorable reimbursement scenario. In terms of growth rate, North America leads with a CAGR of 6.4% followed by Asia Pacific with a CAGR of 6.3%. Asia Pacific represents a highly potential market with a significant growth rate owing to the increasing awareness as well as increasing penetration of market players in the region. The market in Europe ranks third in terms of global market size as well as growth rate while Latin America represents the least market attractiveness index over the forecast period.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/4185
Vendor Insights
Leading players operating in the global herpes marker testing market covered in the report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc. and Teco Diagnostics.
0 notes
Link
Understanding numerous factors of the thermal ablation devices market, Persistence Market Research has put forth a fact based research analysis on the global market for thermal ablation devices in a structured manner in its recent publication titled “Thermal Ablation Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.
0 notes
Link
0 notes
Text
Global Global Biological Testing Market Share, Revenue, Demand and Forecast to 2025
Corneal surgery is a surgical procedure where a damaged or infected cornea is treated by transplantation of corneal tissue. There are two major types of transplantation namely, penetrating keratoplasty and lamellar keratoplasty. An unhealthy or damaged cornea affects the vision by scattering or distorting light and causing glare and blurred vision. Corneal eye disease is the fourth most common cause of blindness after cataracts, glaucoma and age-related macular degeneration.
Causes of damaged cornea include infections such as eye herpes or fungal keratitis, trichiasis, Fuchs' dystrophy, advanced keratoconus, complications from LASIK surgery, chemical burns of the cornea or damage from an eye injury, edema of the cornea, graft rejection following a previous corneal transplant and others.
Rivalry Assessment: Middle East and Africa Corneal Surgery Devices Market
Some of the players in the Middle East and Africa corneal surgery devices market include:
· Carl Zeiss Meditec AG (Germany)
· Abbott Medical Optics Inc. (U.S.)
· Topcon Corporation (Japan)
· Haag-Streit AG (Switzerland)
· Nidek Co. Ltd. (Japan)
· Bausch & Lomb, Inc. (U.S.)
· Ziemer Ophthalmic Systems AG (Switzerland)
Country Analysis: Corneal Surgery Devices Market
Middle East and Africa corneal surgery devices market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countries corneal surgery devices market is growth driven by expansion of businesses by the companies, rise in awareness about ocular disease, and economic growth are expected to propel the market. South Africa corneal surgery devices market is growing at a significant rate owing to adoption of newer surgical devices and high awareness about ocular diseases.
For request sample:
https://precisionbusinessinsights.com/request-sample?product_id=21015
Market Scope: Middle East and Africa Corneal Surgery Devices Market
Middle East and Africa Corneal Surgery Devices Market is segmented on the basis of product type, transplantation type, procedure, end-user, and country
Based on product type, the market is segmented into the following:
· Forceps
· Phaco Choppers
· Spatulas
· Speculums
· Scissors
· Fixiation Rings
· Corneal Markers
· Needle Holders
· Hooks and Manipulators
· Others
Based on the transplantation type, the market is segmented into the following:
· Penetrating Keratoplasty
· Deep Anterior Lamellar Keratoplasty
· Synthetic Corneas
· Others
Based on the procedure, the market is segmented into the following:
· Penetrating Keratoplasty
· Lamellar Keratoplasty
Based on the end user, the market is segmented into the following:
· Hospitals
· Ophthalmic clinics
· Others
Based on the country, the market is segmented into the following:
· Gulf Cooperation Council (GCC) Countries
· Israel
· South Africa
· Rest of MEA
For more information:
https://precisionbusinessinsights.com/market-reports/middle-east-and-africa-corneal-surgery-devices-market/
About precision business insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Contact to Precision Business Insights
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
0 notes
Text
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Growth, Significant Trends Till 2025
According to Data Bridge Market Research new Market report, “Global Enzyme Immunoassay (EIA) Reagents and Devices Market” By Technology(Enzyme Immunoassays, Fluorescent Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassay, and Others), By product type(Analyzers, Reagents),By Application(Oncology, Infectious Diseases, Cardiology, Bone and Mineral, Endocrinology, Autoimmunity, Toxicology, hematology, neonatal screening, and others),By End-Users(Hospitals, Laboratories, Academics, Pharmaceutical Industries {CRO’s, Biotech}, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 11.28 billion by 2025, at a CAGR of 4.2% during the forecast period of 2018 to 2025.
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market
Global Enzyme Immunoassay Reagents and Devices Market
Enzyme Immunoassay (EIA) Reagents and Devices are used to detect the presence of antigen or concentration of an analyteswith its applicability to epidemiological diseases detection and vaccine trials. The basic use is for measurement of drugs, hormones, specific proteins, tumor markers, and markers of cardiac injury. Enzyme immunoassay (EIA) Reagents associated Devices are accustomed discover the presence of substance or concentration of an enzyme with its pertinence to epidemiologic diseases detection and immunizing agent trials.
Immunoassays generally fall into two categories. First, antibody-antigen precipitation tests, such as radial immunodiffusion, hemagglutination, and coated latex particle agglutination. Second, labeled-reagent tests, such as radioimmunoassay, and enzyme-linked immunoassay.
Enzyme immunoassays (EIAs), also known as enzyme-linked immunosorbent assays (ELISAs), combine antibody binding with enzymatic detection to quantify molecules of interest. EIAs are easy to perform, require little specialized equipment, and both the experienced lab technician and the research lab novice can learn EIA skills quickly. EIA is often regarded as the test used to detect HIV.
The enzyme-linked immunosorbent assay (ELISA) is a diagnostic test that uses antibodies and color change to identify a substance. The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality-control check in various industries. Antigens from the sample are attached to a surface. Then, a further specific antibody is applied over the surface so it can bind to the antigen. This antibody is linked to an enzyme, and, in the final step, a substance containing the enzyme’s substrate is added. The subsequent reaction produces a detectable signal, most commonly a color change in the substrate.
Rapid diagnostic tests allowing for the qualitative and quantitative determination of a number of differing analytes hold great potential for acceptance by both laboratory and field personnel. In the clinical laboratory, rapid, sensitive, specific and accurate tests based upon the presence or absence of analyte in biological specimens provide possibilities for the early detection, confirmed diagnosis, and prompt treatment for many pathological conditions. In the field, the potential use of such tests may be extended to determine the presence or absence of differing analytes in air, food, water or soil.
The advantage and acceptance of the diagnostic devices and kits to perform such rapid analysis depends on a number of factors such as sensitivity, specificity, cost per test, ease of use, and timeliness of test results. Ideally, to be accepted by the user, such a device or kit should be simple to perform with rapid, easy to interpret and virtually foolproof results. In addition, such a device should be easily transportable, capable of providing the results of the test “on site”, and disposable after use.
Enzyme immunoassay has wide range of application in clinical laboratories and one of the largest application is related to the detections of viruses. For example, the screening and diagnosis of hepatitis virus is routinely used in the lab. These include the detection of HBsAg and HBeAg by direct ELISA, anti-HBc antibody and anti-HBe antibody by competitive ELISA and anti-HBs antibody by indirect ELISA. What is more, ELISA can detect HCV antibodies in serum samples as screening tests and the positive samples are conformed by molecular HCV RNA.
The Advantageous effect of using an enzyme immunoassay in clinical hematology is that it got the ability to identify alloantibodies in patients who frequently receive platelet transfusions for therapeutic purposes. It has been demonstrated that ELISA is more sensitive to the detection of alloantibodies than other immunoassays, such as Lymphocytotoxic Test (LCT) and the Platelet Immunofluorescence Test (PIFT), and it is performed in a short period of time. Furthermore, enzyme immunoassays are able to detect anti-platelet antibodies, Platelet Associated IgG (PAIgG) , HLA and circulating antibodies in patients with Idiopathic Thrombocytopenic Purpura (ITP).
There are various evidence which suggest that a ubiquitous herpes virus, in particular Epstein-Barr virus (EBV), is implicated in many types of lymphoma such as Hodgkin’s disease and Burkitt’s lymphoma, so the early detection of EBV antigen specific T cells is essential and therefore ELISPOT assay can be used to analyse T cell responses.
Another of its feature is related to acquire von Willebrand syndrome, which is caused by autoantibodies against von Willebrand factor (vWF). This plays an essential role in hemostasis and is characterized by prolonged bleeding due to the defect in vWF activity. Detection of anti-vWF antibody can be performed by ELISA (Mohri 2003), mention that competitive ELISA is a useful technique in the detection of anti-vWFA antibodies in a clinical samples.
Despite the benefits of ELISA in the detection of HLA class I specific antibodies, it is less sensitive than flow cytometry, so before platelet transplantation, flow cytometry must be used. Although chemiluminescence immunoassay has great sensitivity in detecting HBsAg in blood donor samples, it has less sensitivity than the polymerase chain reaction (PCR), so to increase the safety of blood from HIV-1 , HCV, and HBV, the nucleic acid amplification technique (NAT) has been applied for the screening of blood donor samples.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market
Market Segmentation: Global Enzyme Immunoassay Reagents and Devices Market
The global market for Enzyme immunoassay reagents and device by the following sub-categories is presented
· By Application
o Oncology
o Infectious diseases
o Cardiology
o Bone and Mineral
o Endocrinology
o Autoimmunity
o Toxicology
o Hematology
o Neonatal Screening
o Others
· By Technology
o Enzyme immunoassays
o Fluorescent immunoassays
o Chemiluminescence immunoassays
o Radioimmunoassay and others
· By product type
o Analyzers
o Reagents
· By Geography
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
· By End-Users
o Hospitals
o Laboratories
o Academics
o Pharmaceutical Industries
o Others
FACTORS DRIVING GROWTH IN THE GLOBAL ENZYME IMMUNOASSAY REAGENTS AND DEVICES MARKET:
Rising Usage of Novel Biomarkers and Innovative Technologies:
Biomarkers represent powerful tools for diseases detection, determining the efficacy and safety of novel therapeutic agents and monitoring disease recurrence.
Identification of key biomarkers at early stages of diseases that can be easily obtained by the least invasive methods is critical for early diagnosis of cancer diagnosis. Human body fluids, such as blood, present a promising resource for biomarkers. Routine detection of biomarkers is critical to bring substantial advances in molecular medicine and transform many areas of medicine from clinical trials to diagnosis and treatment of complex diseases.
Survival of cancer patients depends heavily on early detection and therefore, developing new technologies allows for a quick, sensitive and cost effective method is critical for cancer research . Early detection is an important factor in determining the survival of patients with hepatocellular carcinoma (HCC). However, early diagnosis of cancer is still difficult to achieve due to the lack of specific symptoms in early stages of the disease where detection of biomarkers is still unattainable due to low detection levels.
Recent advances in detection technologies hold promises to identify novel biomarkers reliably and accurately to predict outcomes during cancer treatment and management. Additionally, the new technologies provide higher analytical capabilities, employing automated liquid handling systems for greater sensitivity, more robust and higher throughput sample analysis.
Rising Incidence of Chronic and Infectious Diseases:
The last half century has seen a steady increase in the incidence and prevalence of chronic inflammatory diseases with further increases expected. This may be due to number of factors such as:
· Misuse of antibiotics especially Beta-lactam antibiotics
· Vitamin supplementation including folic acid but especially vitamin D
· Presence of environmental factors which suppress immunity
· Novel vectors for sharing pathogens including blood donation
· Widespread adoption of compulsory mass vaccinations
Chronic diseases are the largest cause of death in the world. The leading chronic diseases—cardiovascular disease, cancer, chronic respiratory disease, and diabetes—caused 29 million deaths worldwide. Annual mortality due to chronic disease is expected to increase in real numbers as well as relative to deaths from injuries and diseases traditionally understood to be infectious such as polio, rubella, tuberculosis, etc.
The 2014 Ebola outbreak in West Africa dramatically raised awareness of the global burden of infectious disease and raised questions about the preparedness of public health systems. In February 2016, the public scrambled to understand the implications of the Zika virus after the World Health Organization designated it as an international public health emergency because of the suspected relationship between Zika and a rise in cases of a rare congenital condition called microcephaly in Brazil. Although non-communicable diseases are the leading cause of morbidity and mortality in most developed nations, infectious disease remains a major public health concern in the United States and around the world.
A 2014 report by the U.S. Centers for Disease Control and Prevention found that salmonella was responsible for more cases of illness, hospitalizations and deaths than any other food-borne pathogen. A 2012 study published in Lancet Infectious Diseases reviews non-infectious disease risks from mass-gatherings. A 2011 report by the World Health Organization reviewed the causes of death globally, and identified ways by which to measure progress in infectious disease, among other types and indicators of morbidity and mortality.
Some of the major players operating in Enzyme Immunoassay (EIA) Reagents and devicesmarket are
· Novozymes,
· DSM,
· DuPont ,
· Siemens,
· Roche Diagnostics,
· Abbott Laboratories,
· Danaher Corporation,
· Ortho Clinical Diagnostics,
· BioMerieux,
· Randox Laboratories Ltd,
· Biohit Oyj,
· Meril Life Sciences Pvt. Ltd,
· Tosoh Corporation,
· Inova Diagnostics,
· IASON GmbH,
· Radiometer Medical ApS ,
· Lifotronic Technology Co., Ltd,
· PerkinElmer Inc,
· Molecular Devices, LLC ,
· bioMérieux SA,
· HYCOR Biomedical.
Access Full Report: http://databridgemarketresearch.com/reports/global-hla-typing-transplant-diagnostics-services-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
#Global Enzyme Immunoassay (EIA) Reagents and Devices Market report#Global Enzyme Immunoassay (EIA) Reagents and Devices Market trend#Global Enzyme Immunoassay (EIA) Reagents and Devices Market Segments#Global Enzyme Immunoassay (EIA) Reagents and Devices Market growth
0 notes
Text
Herpes Marker Testing Market To Garner US$ 481.8 Million By The End Of 2025
According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’, the global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025). The overall market is anticipated to grow 1.7x in terms of value over the forecast period.
Market Dynamics
Certain factors such as positive diagnostic lab industry dynamics, increasing herpes prevalence, rising awareness, support from various government and non-government organizations, new product approvals and launches, increasing focus on evidence based medicines etc. are boosting revenue growth of the market. However, insufficient R&D initiatives, poor access to diagnostic services in remote areas, pricing pressures, and stringent regulations are some of the factors restricting growth of the market.
Browse Full Research Report:
https://www.persistencemarketresearch.com/market-research/herpes-markers-testing-market.asp
Segmental Forecast
On the basis of test type, the market has been segmented into viral culture test, nucleic acid amplification-based kits and antibody/antigen-based kits. Antibody/Antigen based kits is the highest revenue generating segment over the forecast period owing to the huge product availability as well as high physician preference for this test type. Nucleic Acid Amplification-based kits segment will report the highest growth rate over the forecast period due to the growing acceptance of PCR diagnosis as a gold standard test in herpes testing owing to high sensitivity, specificity and positivity ratio for herpes diagnosis. Antibody/Antigen based kits is projected to be the most attractive segment with an attractiveness index of 1.5 during the forecast period.
Based on the indication, the market has been segmented into HSV-1, HSV-2 and HSV-1/ HSV-2. HSV-1/HSV-2 segment dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. HSV-1/HSV-2 is projected to be the most attractive segment with an attractiveness index of 1.6 and growth rate of 6.5% during the forecast period.
On the basis of application, the market has been segmented into research use and clinical diagnostics segment. Clinical diagnostics application dominates the market for herpes marker testing with a value share in excess of 85% throughout the forecast period.
Request and Download Sample Report@
https://www.persistencemarketresearch.com/samples/4185
Based on end user, the market has been segmented into hospitals, diagnostics centers, clinics and academic & research institutes. Among all the end users, most of the revenue is generated via the diagnostic centers sales followed by hospitals owing to the maximum number of tests being performed at these facilities. Diagnostics centers dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. This segment represents a market attractiveness index of 1.6 over the forecast period.
Among the regional markets, North America holds the maximum value share in the global market owing to the accessibility and affordability of diagnostic services in the region and a favorable reimbursement scenario. In terms of growth rate, North America leads with a CAGR of 6.4% followed by Asia Pacific with a CAGR of 6.3%. Asia Pacific represents a highly potential market with a significant growth rate owing to the increasing awareness as well as increasing penetration of market players in the region. The market in Europe ranks third in terms of global market size as well as growth rate while Latin America represents the least market attractiveness index over the forecast period.
Vendor Insights
Leading players operating in the global herpes marker testing market covered in the report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc. and Teco Diagnostics.
Buy Full Herpes Marker Testing Market Report
@ https://www.persistencemarketresearch.com/checkout/4185
0 notes
Last Seen Blogs
rollercoasterbirthdays
Roller Coaster Birthdays!
olgadesign
беца
sadi-fics
Sadi RP and Fanfics
pearly-boi
Bees In My Soup
dopeybois
a gross world for gross boys :>